The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression

Cell Growth and Differentiation

Volumn 7, Issue 1, 1996, Pages 53-64

  Sterner, Jacqueline M ^a   Tao, Yunxia ^a   Kennett, Sarah B ^a   Kim, Hyung Goo ^a   Horowitz, Jonathan M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PHOSPHOAMINO ACID; PROTEIN SERINE KINASE; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN;

AMINO ACID ANALYSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LUNG ADENOCARCINOMA; ONCOGENE C MYC; PRIORITY JOURNAL; RETINOBLASTOMA; TRANSCRIPTION REGULATION; TUMOR GROWTH;

BASE SEQUENCE; CYCLIN-DEPENDENT KINASES; GROWTH INHIBITORS; HUMANS; LEUKEMIA, MYELOID; MATURATION-PROMOTING FACTOR; MITOSIS; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030071309     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Lee, E. Y-H. P., To, H., Shew, J-Y., Bookstein, R., Scully, P., and Lee, W-H Inactivation of the retinoblastoma susceptibility gene in human breast cancers Science (Washington DC), 241. 218-221, 1988.
2. T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., and Fung, Y-K. T. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science (Washington DC), 242: 263-266, 1988.
3. Yokota, J T., Akiyama, T., Fung, Y-K. T., Benedict, W. F., Namba, Y., Hanaoka, M., Wada, M., Terasaki, T., Shimosato, Y , Sugimura, T., and Terada, M. Altered expression of the retinoblastoma (Rb) gene in small-cell carcinoma of the lung. Oncogene, 3: 471-475, 1988.
4. Horowitz, J. M., Yandell, D W., Park, S-H., Canning, S., Whyte, P , Buchkovich, K. J., Harlow, E., Weinberg, R. A., and Dryja, T. P. Point mutational inactivation of the retinoblastoma antioncogene. Science (Washington DC), 243: 937-940, 1989.
5. Horowatz, J. M., Park, S-H., Bogenmann, E , Cheng, J-C., Yandell, D. W., Kaye, F. J , Minna, J D., Dryja, T. P., and Weinberg, R. A. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA, 87: 2775-2779, 1990.
6. Hong, F. D., Huang, H-J. S., To, H., Young, L-J. S., Oro, A., Bookstein, R., Lee, E. Y-H. P. and Lee, W-H. Structure of the human retinoblastoma gene. Proc. Natl. Acad. Sci. USA, 86: 5502-5506, 1989.
7. McGee, T. L., Yandell, D. W., and Dryja, T. P. Structure and partial sequence of the human retinoblastoma susceptibility gene. Gene (Amst.), 80: 119-128, 1989.
8. T'Ang, A., Wu, K-J., Hashimoto, T., Liu, W-Y., Takahashi, R., Shi, X-H., Mihara, K., Zhang, F-H., Chen, Y. Y., Du, C., Qian, J., Lin, Y-G., Murphree, A. L., Qiu, W-R., Thompson, T., Benedict, W. F., and Fung, Y-K. T. Genomic organization of the human retinoblastoma gene. Oncogene, 4: 401-407, 1989.
9. Lee, W-H., Shew, J-Y., Hong, F. D., Sery, T. W., Donoso, L A., Young, L-J., Bookstein, R., and Lee, E. Y-H. P. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (Lond.), 329: 642-645, 1987.
10. Bernards, R., Shackleford, G. M., Gerber, M R., Horowitz, J. M., Friend, S. H , Schartl, M., Bogenmann, E , Rapaport, J. M., McGee, T., Dryja, T. P., and Weinberg, R. A. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl. Acad. Sci. USA, 36: 6474-6478, 1989.
11. Ewen, M. E., Xing, Y., Lawrence, J. B., and Livingston, D M. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell, 66: 1155-1164, 1991.
12. Li, Y., Graham, C., Lacy, S., Duncan, A. M. V., and Whyte, P. The adenovirus E1A-assoctated 130kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes & Dev., 7: 2366-2377, 1993.
13. Hannon, G. J., Demetrick, D., and Beach, D. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins Genes & Dev., 7: 2378-2391, 1993.
14. Mayol, X., Grana, X., Baldi, A., Sang, N , Hu, Q., and Giordano, A. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene, 8: 2561-2566, 1993
15. Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D. M., Dyson, N., and Harlow, E. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes & Dev , 7: 1111-1125, 1993.
16. Vairo, G , Livingston, D. M., and Ginsberg, D. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes & Dev., 9. 869-881, 1995.
17. Claudio, P. P., Howard, C. M., Baldi, A., De Luca, A., Fu, Y., Condorelli, G., Sun, Y., Colburn, N., Calabretta, B., and Giordano, A. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res., 54: 5556-5560, 1994.
18. Smith, E. J., and Nevins, J. R. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2. Mol. Cell. Biol., 75: 338-344, 1995.
19. Buchkovich, K., Duffy, L. A., and Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58: 1097-1105, 1989.
20. Chen, P-L., Scully, P., Shew, J-Y., Wang, J. Y. J., and Lee, W-H. Phosphorylation of the retinoblastoma gene product is modified during the cell cycle and cellular differentiation. Cell, 53: 1193-1198, 1989.
21. DeCapno, J. A., Ludlow, J. W , Lynch, D., Furukawa, Y., Griffin, J., Piwinica-Worms, H., Huang, C-M , and Livingston, D. M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell, 58: 1085-1095, 1989.
22. Mihara, K., Cao, X-R., Yen, A., Chandler, S., Driscoli, B., Murphree, A. L., T'Ang, A. and Fung, Y.-K T. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science (Washington DC), 246: 1300-1303, 1989.
23. Furukawa, Y., DeCaprio, J. A., Freedman, A., Kanahura, Y , Nakamura, M., Ernst, T. J., Livingston, D. M., and Griffin, J. D. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA, 87: 2770-2774, 1990.
24. Ludlow, J. W., Glendening, C. L., Livingston, D. M., and DeCaprio, J. A. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell. Biol., 13: 367-372, 1993.
25. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
26. Hatakeyama, M., Brill, J. A., Fink, G. R., and Weinberg, R. A. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes & Dev., 8: 1759-1771, 1994.
27. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821-1828, 1994.
28. 2 arrest. Mol. Cell. Biol., 13: 6640-6652, 1993.
29. Bookstein, R., Shew, J-Y., Chen, P-L., Scully, P., and Lee, W-H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (Washington DC), 247: 712-715, 1990.
30. Rubin, S. J., Hallahan, D. E., Ashman, C. R., Brachman, D. G., Beckett, M. A , Virudachalam, S., Yandell, D. W., and Weichselbaum, R. R. Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. J. Surg. Oncol., 46: 31-36, 1991.
31. Mori, N., Yokota, J., Akiyama, T., Sameshima, Y , Okamoto, A., Mizoguchi, H., Toyoshima, K., Sugimura, T., and Terada, M. Variable mutations of the Rb gene in small-cell lung carcinoma. Oncogene, 5: 1713-1717, 1990.
32. Shew, J-Y., Chen, P-L., Bookstein, R., Lee, E Y-H. P., and Lee, W-H. Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen. Cell Growth & Differ., 1: 17-25, 1990.
33. Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
34. Onadim, Z., Hogg, A., Baird, P. N., and Cowell, J. K. Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinobiastoma phenotype. Proc. Natl. Acad. Sci. USA, 89: 6177-6181, 1992.
35. Bignon, Y-J., Shew, J-Y., Rappolee, D., Naylor, S. L., Lee, E. Y-H. P., Schnier, J., and Lee, W-H. A single Cys706 to Phe substitution in the retinoblastoma protein causes the loss of binding to SV40 T antigen Cell Growth & Differ., 1 647-651, 1990.
36. Kaye, F J., Kratzke, R. A., Gerster, J. L., and Horowitz, J. M. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl. Acad. Sci. USA, 87: 6922-6926, 1990.
37. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J-Y., and Livingston, D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73: 487-497, 1993.
38. Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., and Weinberg, R A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70: 993-1006, 1992.
39. Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., and Nevins, J. R. The E2F transcription factor is a cellular target for the Rb protein. Cell, 65: 1053-1061, 1991.
40. Chittenden, T., Livingston, D. M., and Kaelin, W. G., Jr. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell, 65: 1073-1082, 1991.
41. Kaelin, W. G., Jr., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., and Livingston, D. M. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell, 64: 521-532, 1991.
42. Kaelin, W. G., Jr., Krek, W., Sellers, W. R., DeCaprio, J A., Ajchenbaum, F., Fuchs, C. S., Chittenden, T., Li, Y., Farnham, P. J., Blanar, M. A., Livingston, D M., and Flemington, E. K. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell, 70: 351-364, 1992.
43. DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J-Y., Huang, C-M., Lee, W-H., Marsilio, E., Paucha, E., and Livingston, D. M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell, 54: 275-282, 1988.
44. Dyson, N., Howley, P. M , Munger, K., and Harlow, E. The human Papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
45. Dyson, N., Bernards, R., Friend, S. H., Gooding, L R., Hassell, J. A., Major, E. O., Pipas, J. M., Vandyke, T., and Harlow, E. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J. Virol., 64: 1353-1356, 1990.
46. Whyte, P., Buchkovich, K. J., Horawitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., and Harlow, E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma susceptibility gene product. Nature (Lond.), 334: 124-129, 1988.
47. Rustgi, A., Dyson, N., and Bernards, R. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature (Lond.), 352: 541-544, 1991.
48. Kim, S-J., Wagner, S., Liu, F., O'Reilly, M. A., Robbins, P. D., and Green, M. R. Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature (Lond.), 358: 331-334, 1992.
49. Wang, C-Y., Petryniak, B., Thompson, C. B., Kaelin, W. G., Jr., and Leiden, J. M. Regulation of the ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science (Washington DC), 260: 1330-1334, 1993.
50. Udvadia, A. J., Rogers, K. T., Higgins, P. D. R., Murata, Y., Martin, K. H., Humphrey, P. A., and Horowitz, J. M. Sp-1 binds promoter elements regulated by the Rb protein and Sp-1-mediated transcription is stimulated by Rb co-expression. Proc. Natl. Acad. Sci. USA, 90: 3265-3269, 1993.
51. Kim, S-J., Onwuta, U. S., Lee, Y. I., Li, R., Botchan, M. R., and Robbins, P. D. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol , 12: 2455-2463, 1992.
52. Udvadia, A. J., Templeton, D. J., and Horowitz, J. M. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression Proc. Natl. Acad. Sci. USA, 92: 3953-3957, 1995.
53. Wu, C-L., Zukerberg, L R., Ngwu, C , Harlow, E., and Lees, J. A. In vivo association of E2F and DP family proteins. Mol. Cell. Biol., 15: 2536-2546, 1995.
54. Gu, W., Schneider, J. W., Condorelli, G., Kaushai, S., Mahdavi, V., and Nadal-Ginard, B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell, 72: 309-324, 1993.
55. Nevins, J. R. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science (Washington DC), 258: 424-429, 1992.
56. 1 phase arrest induced by RB protein but not by p53. Nature (Lond.), 360: 177-179, 1992.
57. 1 phase of the cell cycle. Cell, 67: 293-302, 1991.
58. Qin, X-q., Chittenden, T., Livingston, D. M., and Kaelin, W G., Jr. Identification of a growth suppression domain within the retinoblastoma gene product. Genes & Dev., 6: 953-964, 1992
59. Dryja, T. P., Rapaport, J., McGee, T. L., Nork, T M., and Schwartz, T. L. Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am. J. Hum. Genet., 52: 1122-1128, 1993.
60. Hogg, A , Bia, B., Onadim, Z., and Cowell, J. K. Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma. Proc. Natl. Acad. Sci. USA, 90: 7351-7355, 1993.
61. Qian, Y , Luckey, C , Horton, L., Esser, M., and Templeton, D. J. Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol. Cell. Biol., 12: 5363-5372, 1992.
62. 2/M phases. J. Biol. Chem., 270: 9281-9288, 1995.
63. Lees, J. A., Buchkovich, K. J., Marshak, D. R , Anderson, C. W., and Harlow, E The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J., 10: 4279-4290, 1991.
64. Weintraub, S. J., Chow, K. N. B., Luo, R. X., Zhang, S. H., He, S , and Dean, D. C. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature (Lond.), 375: 812-815, 1995.
65. Adriane, J , and Bobbins, P. D. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription. Oncogene, 10: 381-387, 1995.
66. Alvarez, E., Northwood, I C., Gonzalez, F. A., Latour, D. A., Alpna, S., Abate, C., Curran, T., and Davis, R. J. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. J. Biol. Chem., 266: 15277-15285, 1991.
67. Lutterbach, B., and Hann, S. R. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-myc protein is regulated by mitogens and in mitosis. Mol. Cell. Biol , 14: 5510-5522, 1994.
68. Alpna, S., Gupta, S., and Davis. R. J. Cell cycle regulation of the c-myc transcriptional activation domain. Mol. Cell. Biol., 13: 4125-4136, 1993.
69. Alpna, S., Alvarez, E., Gupta, S., and Davis, R. J. A phosphorylation site located in the NH2-terminal domain of c-myc increases transactivation of gene expression. J. Biol. Chem., 266: 23521-23524, 1991.
70. Dyson, N., Buchkovich, K., Whyte, P., and Harlow, E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell, 53: 249-255, 1989.
71. Svensson, C., Bondesson, E., Nyberg, E., Linder, S., Jones, N , and Akusjarvi, G. Independent transformation activity by adenovirus-5 E1A-conserved region 1 or 2 mutants. Virology, 182: 553-561, 1992.
72. Howe, J. A., and Bayley, S. T. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A. Virology, 186: 15-24, 1992.
73. Schwarz, J. K., Devoto, S H., Smith, E. J., Chellappan, S. P., Jakoi, L., and Nevins, J. R. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J., 12: 1013-1020, 1993.
74. Shirodkar, S., Ewen, M., DeCaprio, J. A., Morgan, J., Livingston, D. M., and Chittenden, T. The transcription factor E2F interacts with the retinoblastoma product and p107-cyclin A complex in a cell cycle-regulated manner. Cell, 68: 157-166, 1992.
75. 2/M by p53. Oncogene, 10: 109-115, 1995.
76. 2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res., 55: 1763-1773, 1995.
77. 2 delay. Cancer Res., 55: 1643-1648, 1995.
78. Hoang, A. T., Lutterbach, B., Lewis, B. C., Yano, T., Chou, T-Y , Barrett, J F., Raffeld, M., Hann, S. R., and Dang, C. V. A link between increased transforming activity of lymphoma-derived myc mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-myc transactivation domain. Mol. Cell. Biol., 75: 4031-4042, 1995.
79. Gu, W., Bhatia, K , Magrath, I. T., Dang, C. V., and Dalla-Favera, R Binding and suppression of the mye transcriptional activation domain by p107. Science (Washington DC), 264: 251-254, 1994.
80. Beijersbergen, R. L., Hijmans, E. M., Zhu, L., and Bernards, R. Interaction of c-myc with the pRb-related protein p107 results in inhibition of c-myc-mediated transactivation. EMBO J., 13: 4080-4086, 1994.
81. Murata, Y., Kim, H. G., Rogers, K. T., Udvadia, A. J., and Horowitz, J. M. Negative regulation of Sp1 trans-activation is correlated with the binding of cellular proteins to the ammo terminus of the Sp1 transactivation domain. J. Biol. Chem., 269: 20674-20681, 1994.
82. Horton, L. E., Qian, Y., and Ternpleton, D. J. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms. Cell Growth & Differ., 6: 395-407, 1995.
83. Musil, L. S., Cunningham, B. A., Edelman, G. M., and Goodenough, D. A. Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J Cell Biol., 111: 2077-2088, 1990.